Anzeige
Mehr »
Login
Dienstag, 19.03.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Mega-Kurskatalysator - Vorbereitung der Phase-3 Studie soeben bestätigt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von RTTNews

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12:29Pembina Pipeline Says Canada OKs Proposed Acquisition Of Enbridge's Interest In Alliance/Aux Sable
12:29CSL Vifor Announces Health Canada Approval For Ferinject
12:29Unilever To Separate Ice Cream Unit, To Cut 7,500 Jobs; Stock Up
12:29Caleres Inc. Q4 Profit Increases, beats estimates
11:59Krispy Kreme Unveils All-New Spring Mini Doughnuts
11:59Crinetics Pharma Reports Positive Results From Phase 3 Studies Of Paltusotine For Acromegaly
11:59XPeng Posts Narrower Loss In Q4; Revenues From Vehicle Sales Up 162.3%
10:59Tencent Music Entertainment Q4 Profit Rises, Revenues Down
09:29DEUTZ Group FY23 Adj. EBIT Rises; Revenue Up 7.8%
08:59PureTech Health Proposes Capital Return
08:29Crest Nicholson Issues Trading Update
07:59FDA Approves First Gene Therapy For Kids With Early-onset MLD
03:59JOYY Turns To Profit In Q4
02:59Innovent: Phase 2 Trial Of IBI302 In Neovascular Age-related Macular Degeneration Meets Main Goal
MoSony Halts PS VR2 Production: Report
MoCanoo's Oklahoma City Manufacturing Unit Approved As Foreign Trade Zone; Stock Soars
MoNokia Launches First Phase Of EUR 300 Mln Share Buyback Plan
MoCustom Truck One Source Acquires SOS Fleet Services In Alexandria
MoCitius Pharmaceuticals Announces Acceptance Of BLA Resubmission For LYMPHIR
MoSAIC Falls In Pre-market After Profit, Revenue Drop In Q4
MoMobileye To Wind Down Aftermarket Solutions Unit
MoBrand Engagement Network Surges 20% In Pre-market
MoSpyre Therapeutics Privately Places $180 Mln Of Shares; Stock Up In Pre-Market
MoBluebird Bio Secures Debt Financing
MoEmbraer Reports 2023 Results; Issues 2024 Guidance